A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 9/00 (2006.01) A61K 9/20 (2006.01) A61K 31/165 (2006.01)
Patent
CA 2660138
The present invention relates to a dosage form for transmucosal administration comprising a therapeutically effective amount of aliskiren or a pharmaceutically acceptable salt thereof, and an excipient for transmucosal delivery, wherein the active ingredient is present in an amount of 0.001 to 80% by weight based on the total weight of the dosage form.
L'invention concerne une forme galénique pouvant être administrée par voie transmuqueuse, comprenant une quantité thérapeutiquement efficace d'aliskirène ou d'un de ses sels pharmaceutiquement acceptable, et un excipient permettant l'administration par voie transmuqueuse. La teneur en principe actif est comprise entre 0,001 et 80% en poids sur la base du poids totale de la forme galénique.
Fetherstonhaugh & Co.
Novartis Ag
LandOfFree
Galenic formulations of organic compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Galenic formulations of organic compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Galenic formulations of organic compounds will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1648835